Fig 1: (A) ELISA validation of AMBP and RBP4 in serum samples of healthy controls, patients with inactive SLE and patients with active SLE in Cohort II (from Hong Kong). (B) ROC curves of serum AMBP and RBP4, displaying their ability to distinguish different groups of subjects, as indicated. ns, non-significant; **p<0.01; ***p<0.001; ****p<0.0001. AMBP, alpha-1-microglobulin/bikunin precursor; AUC, area under the curve; RBP4, retinol-binding protein 4; ROC, receiver operating characteristic; SLE, systemic lupus erythematosus.
Fig 2: ELISA validation of hits from iTRAQ screen in Cohort I. (A) ELISA validation of AMBP, AZGP and RBP4 levels in serum samples from healthy controls, patients with inactive SLE and patients with active SLE in Cohort I (from UTSW). (B) ROC curves of serum AMBP, AZGP and RBP4, displaying their ability to distinguish different groups of subjects, as indicated. *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001. AMBP, alpha-1-microglobulin/bikunin precursor; AUC, area under the curve; AZGP, zinc alpha-2 glycoprotein; iTRAQ, isobaric tags for relative and absolute quantitation; RBP4, retinol-binding protein 4; ROC, receiver operating characteristic; SLE, systemic lupus erythematosus; UTSW, University of Texas Southwestern.
Supplier Page from Abcam for Human alpha 1 Microglobulin ELISA Kit